NEW YORK, Jan. 03, 2023, a global leader in genomics and precision medicine, is pleased to announce that the Company will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco next
Dante Genomics, a global leader in genomics and precision medicine, is pleased to announce that the Company will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco next week. Andrea Riposati, CEO of Dante Genomics, will present on Tuesday, January 10, 2023 at 4:30 PM Pacific Time at The .
- Dante Genomics uses the 1health.io platform to accelerate their go to market strategy and expand availability in all 50 states using the 1health online prescription services -NEW YORK, Dec. 07, 2022Inc.
Investegate announcements from Dante Genomics, Dante Genomics launches doctor ordered, clinical whole genome sequencing in the U.S. in partnership with 1health.io